JPH10512784A - 患者スクリーニング用マーカー - Google Patents
患者スクリーニング用マーカーInfo
- Publication number
- JPH10512784A JPH10512784A JP8522908A JP52290896A JPH10512784A JP H10512784 A JPH10512784 A JP H10512784A JP 8522908 A JP8522908 A JP 8522908A JP 52290896 A JP52290896 A JP 52290896A JP H10512784 A JPH10512784 A JP H10512784A
- Authority
- JP
- Japan
- Prior art keywords
- patient
- brain
- marker
- nervous system
- profile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012216 screening Methods 0.000 title claims abstract description 11
- 210000004556 brain Anatomy 0.000 claims abstract description 79
- 239000003550 marker Substances 0.000 claims abstract description 56
- 208000012902 Nervous system disease Diseases 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 35
- 230000005714 functional activity Effects 0.000 claims abstract description 21
- 230000000926 neurological effect Effects 0.000 claims abstract description 14
- 208000024827 Alzheimer disease Diseases 0.000 claims description 15
- 208000018737 Parkinson disease Diseases 0.000 claims description 14
- 238000009826 distribution Methods 0.000 claims description 13
- 238000002599 functional magnetic resonance imaging Methods 0.000 claims description 10
- 208000030507 AIDS Diseases 0.000 claims description 9
- 208000025500 Hutchinson-Gilford progeria syndrome Diseases 0.000 claims description 8
- 208000007932 Progeria Diseases 0.000 claims description 8
- 208000025434 cerebellar degeneration Diseases 0.000 claims description 8
- 230000006870 function Effects 0.000 claims description 8
- 208000014094 Dystonic disease Diseases 0.000 claims description 7
- 208000010118 dystonia Diseases 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 3
- 238000011551 log transformation method Methods 0.000 claims description 3
- 238000002603 single-photon emission computed tomography Methods 0.000 claims description 3
- 230000000877 morphologic effect Effects 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 28
- 201000010099 disease Diseases 0.000 description 22
- 238000002600 positron emission tomography Methods 0.000 description 14
- 230000000875 corresponding effect Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 7
- 230000002503 metabolic effect Effects 0.000 description 7
- 230000032683 aging Effects 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 230000003925 brain function Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 208000015122 neurodegenerative disease Diseases 0.000 description 5
- 238000002610 neuroimaging Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 206010061818 Disease progression Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 238000002591 computed tomography Methods 0.000 description 4
- 230000005750 disease progression Effects 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000003748 differential diagnosis Methods 0.000 description 3
- 238000000554 physical therapy Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000007177 brain activity Effects 0.000 description 2
- 210000004720 cerebrum Anatomy 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- ZCXUVYAZINUVJD-AHXZWLDOSA-N 2-deoxy-2-((18)F)fluoro-alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H]([18F])[C@@H](O)[C@@H]1O ZCXUVYAZINUVJD-AHXZWLDOSA-N 0.000 description 1
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000110847 Kochia Species 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000006736 behavioral deficit Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 201000004559 cerebral degeneration Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/037—Emission tomography
Landscapes
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Data Mining & Analysis (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Nuclear Medicine (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.所定の脳形態の予め定められた座標の複数のセットにおける、予め定められ た機能的活動のプロファイルを含むところの、神経系障害についての患者のスク リーニングにおいて使用されるマーカー。 2.予め定められた座標の各セットが、それに付随し、機能的活動に対応する単 一の数値を有する請求項1に従うマーカー。 3.座標の各セットが患者の脳の関心のある領域に対応する請求項1に従うマー カー。 4.各関心のある領域が約1cm3以下の体積を有する請求項3に従うマーカー 。 5.各関心のある領域が、対応する脳スキャンの少くとも1つのスライスの少く とも1つのピクセルを含む請求項3に従うマーカー。 6.プロファイルが、対応する脳スキャンの各スライスについての値の配列を含 む請求項5に従うマーカー。 7.パーキンソン病、アルツハイマー病、変形性筋緊張異常、小脳変性、うつ病 、早老症、及び神経AIDSのうちの一つについての請求項1に従うマーカー。 8.患者の脳の実際の機能的活動の患者プロファイルを作るステップと、患者プ ロファイルを、所定の脳形態の予め定められた座標の複数のセットにおける予め 決定された機能的活動のプロファイルを含む少なくとも1つのマーカー と比較するステップを含む、患者を神経系障害についてスクリーニングする方法 。 9.比較するステップが、患者プロファイルを種々の神経系障害についての複数 のマーカーと比較することを含む請求項8に従う方法。 10.複数のマーカーが、パーキンソン病、アルツハイマー病、変形性筋緊張異 常、小脳変性、うつ病、早老症、神経AIDSから選ばれる神経系障害について のものである請求項9に従う方法。 11.患者プロファイルを作るステップが、所定の脳形態の予め定められた座標 の複数のセットに対応する患者の脳の複数の関心のある領域の機能的活動の数値 を計算することを含む請求項8に従う方法。 12.計算のステップが各関心のある領域について単一の数値を作ることを含む 請求項11に従う方法。 13.所定の脳形態の予め定められた座標の複数のセットにおける予め決定され た機能的活動のプロファイルを含むところの神経系障害についての少くとも1つ のマーカーを記憶するメモリーと、所定の脳形態の予め定められた座標の複数の セットに対応する、患者の脳の複数の関心のある領域の各々についての、患者の 機能的活動のプロファイルを作るための、患者の脳の機能的活動に対応するデー ターを受容するプリプロセッサーと、患者プロファイルを少くとも1つのマーカ ーと相互相関させるプロセッサーと、神経系障害の存在または進行度を相互相関 の共分散度の関数 として決定するポストプロセッサーとを含むところの、患者における神経系障害 の存在または進行度を決定するための装置。 14.プリプロセッサーに与えられるデーターを作成するために患者の脳をスキ ャンニングするためのスキャナーをさらに含む請求項13に従う装置。 15.スキャナーがPETスキャナー、SPECTスキャナー及び機能的MRI スキャナーのうちの1つを含む請求項14に従う装置。 16.プリプロセッサーがデーターをフィルターするための空間フィルターを含 む請求項13に従う装置。 17.プリプロセッサーがフィルターされたデーターにlog変換を施す回路を さらに含む請求項16に従う装置。 18.ポストプロセッサーが、患者のマーカースコアを作るために共分散度をリ スケールするための回路を含む請求項13に従う装置。 19.ポストプロセッサーが、患者について障害の進行度を決定するために、患 者マーカースコアを従前の患者マーカースコアと比較する回路をさらに含む請求 項18に従う装置。 20.メモリーに記憶された複数のマーカーを含み、プロセッサーが患者プロフ ァイルを複数のマーカーと相互相関させる請求項13に従う装置。 21.複数のマーカーが、アルツハイマー病、変形性筋緊張異常、小脳変性、パ ーキンソン病、神経AIDS、うつ 病、及び早老症からなる群より選ばれる神経系障害についてのものである請求項 20に従う装置。 22.スキャナーがプリプロセッサーから遠隔にあり、データーをスキャナーか らプリプロセッサへ転送するためのデーター通信回路をさらに含む請求項14に 従う装置。 23.所定の脳形態の予め定められた座標の複数のセットにおける予め決定され た機能的活動のプロファイルを含むところの神経系障害についての少くとも1つ のマーカーを用意するステップ、所定の脳形態の予め定められた座標の複数のセ ットに対応する、患者の脳の複数の関心のある領域の各々についての患者の脳の 機能的活動の患者プロファイルを作り出すステップ、患者プロファイルを少くと も1つのマーカーと相互相関させるステップ、及び神経系障害の存在または進行 度を相互相関における共分散度の関数として決定するステップを含む、患者にお ける神経系障害の存在または進行度を決定する方法。 24.患者プロファイルを作成するためのデーターを作るために患者の脳をスキ ャンニングすることをさらに含む請求項23に従う方法。 25.スキャンニングがPETスキャンニング、SPECTスキャンニング及び 機能的MRIスキャンニングのうちの1つを含む請求項24に従う方法。 26.患者プロファイルを作り出すステップがデーターを空間的にフィルターす ることを含む請求項24に従う方法。 27.患者プロファイルを作り出すステップがフィルター されたデーターにlog変換を施すことをさらに含む請求項26に従う方法。 28.神経系障害の存在または進行度を決定するステップが、マーカーについて の患者スコアを出すために共分散度をリスケールすることを含む請求項23に従 う方法。 29.神経系障害の存在または進行度を決定するステップが、マーカーについて の患者スコアをそのマーカーについての従前の患者スコアと比較することをさら に含む請求項28に従う方法。 30.複数のマーカーを用意し、且つ患者のプロファイルを相互相関させるステ ップが複数のマーカーと相互相関させること含む請求項23に従う方法。 31.複数のマーカーが、アルツハイマー病、変形性筋緊張異常、小脳変性、パ ーキンソン病、神経AIDS、うつ病、及び早老症からなる群より選ばれる神経 系障害についてのものである請求項30に従う方法。 32.スキャンニングが患者プロファイルの作成から遠隔で遂行され、且つスキ ャナーからデーターを転送することをさらに含む請求項24に従う方法。 33.神経系障害の存在または進行度を決定するステップが、患者スコアを、所 定の神経系障害を有する患者母集団の患者スコアの分布と、種々の神経系障害を 有する患者母集団の患者スコアの分布と、及び所定の神経系障害を有しない患者 母集団の患者スコアの分布と比較することをさらに含む請求項28に従う方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/379,056 | 1995-01-27 | ||
US08/379,056 US5632276A (en) | 1995-01-27 | 1995-01-27 | Markers for use in screening patients for nervous system dysfunction and a method and apparatus for using same |
PCT/US1996/000568 WO1996022729A1 (en) | 1995-01-27 | 1996-01-11 | Markers for use in screening patients |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006221155A Division JP2007018524A (ja) | 1995-01-27 | 2006-08-14 | 患者スクリーニング用マーカー |
JP2007102591A Division JP4309931B2 (ja) | 1995-01-27 | 2007-04-10 | 神経系障害のスクリーニング装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10512784A true JPH10512784A (ja) | 1998-12-08 |
Family
ID=23495638
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8522908A Pending JPH10512784A (ja) | 1995-01-27 | 1996-01-11 | 患者スクリーニング用マーカー |
JP2006221155A Pending JP2007018524A (ja) | 1995-01-27 | 2006-08-14 | 患者スクリーニング用マーカー |
JP2007102591A Expired - Fee Related JP4309931B2 (ja) | 1995-01-27 | 2007-04-10 | 神経系障害のスクリーニング装置 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006221155A Pending JP2007018524A (ja) | 1995-01-27 | 2006-08-14 | 患者スクリーニング用マーカー |
JP2007102591A Expired - Fee Related JP4309931B2 (ja) | 1995-01-27 | 2007-04-10 | 神経系障害のスクリーニング装置 |
Country Status (7)
Country | Link |
---|---|
US (2) | US5632276A (ja) |
EP (1) | EP0869736A4 (ja) |
JP (3) | JPH10512784A (ja) |
AU (1) | AU4898796A (ja) |
CA (1) | CA2211537C (ja) |
IL (1) | IL116866A (ja) |
WO (1) | WO1996022729A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008501957A (ja) * | 2004-06-02 | 2008-01-24 | シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド | 陽電子放射断層撮影法画像を用いた統計学的分析によるアルツハイマー病の自動化された検出 |
JP2008026144A (ja) * | 2006-07-21 | 2008-02-07 | Fujifilm Ri Pharma Co Ltd | 画像診断支援システム及び方法 |
JP4302183B1 (ja) * | 2008-07-28 | 2009-07-22 | 日本メジフィジックス株式会社 | 脳神経疾患検出技術 |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2751109B1 (fr) * | 1996-07-09 | 1998-10-09 | Ge Medical Syst Sa | Procede de localisation d'un element d'interet contenu dans un objet tridimensionnel, en particulier lors d'un examen de stereotaxie en mammographie |
US20030144875A1 (en) * | 1997-09-06 | 2003-07-31 | Suffin Stephen C. | EEG prediction method for medication response |
US6622036B1 (en) | 2000-02-09 | 2003-09-16 | Cns Response | Method for classifying and treating physiologic brain imbalances using quantitative EEG |
CA2304592A1 (en) * | 1997-09-24 | 1999-04-01 | The General Hospital Corporation | Inhibition of psychostimulant-induced and nicotine-induced craving |
US6351549B1 (en) | 1997-10-24 | 2002-02-26 | Ultratouch Corporation | Detection head for an apparatus for detecting very small breast anomalies |
US6070095A (en) * | 1998-06-02 | 2000-05-30 | General Electric Company | Method for reducing translational motion artifacts in MR imaging |
DE19855671A1 (de) * | 1998-12-02 | 2000-06-15 | Siemens Ag | Verfahren zur zeit- und ortsaufgelösten Darstellung funktioneller Gehirnaktivitäten mittels magnetischer Resonanz und Vorrichtung zur Durchführung des Verfahrens |
US6463321B2 (en) | 1999-08-10 | 2002-10-08 | Thuris Corporation | Method and computer program product for assessing neurological conditions and treatments using evoked response potentials |
US6223074B1 (en) | 1999-08-10 | 2001-04-24 | Thuris Corporation | Method and computer program product for assessing neurological conditions and treatments using evoked response potentials |
US7076437B1 (en) | 1999-10-29 | 2006-07-11 | Victor Levy | Process for consumer-directed diagnostic and health care information |
US6907280B2 (en) * | 1999-12-02 | 2005-06-14 | The General Hospital Corporation | Method and apparatus for objectively measuring pain, pain treatment and other related techniques |
WO2001039664A1 (en) * | 1999-12-02 | 2001-06-07 | The General Hospital Corporation | Method and apparatus for measuring indices of brain activity |
US7087015B1 (en) * | 2000-01-31 | 2006-08-08 | Panmedix, Inc. | Neurological pathology diagnostic apparatus and methods |
US6356781B1 (en) * | 2000-03-31 | 2002-03-12 | Lucent Technologies, Inc. | Functional magnetic resonance imaging capable of detecting the occurrence of neuronal events with high temporal accuracy |
WO2001095947A1 (en) * | 2000-06-13 | 2001-12-20 | The Mclean Hospital Corporation | Method for assessing cortical response to blue light |
WO2002039891A1 (en) * | 2000-10-06 | 2002-05-23 | Ultratouch Corporation | A dynamic health metric reporting method and system |
EP2275959A3 (en) * | 2001-07-11 | 2011-04-06 | CNS Response, Inc. | Method of screening a therapeutic agent for therapeutic effectiveness |
US20040030672A1 (en) * | 2001-08-01 | 2004-02-12 | Garwin Jeffrey L | Dynamic health metric reporting method and system |
US20030211459A1 (en) * | 2001-10-25 | 2003-11-13 | The General Hospital Corporation | Drug development by rapid neuroimaging of neural cells |
US20030229107A1 (en) * | 2001-11-02 | 2003-12-11 | Ronald Cowan | Magnetic resonance with stimulation |
US7587234B2 (en) * | 2001-11-02 | 2009-09-08 | Abbott Cardiovascular Systems Inc. | Method and apparatus for computer modified magnetic resonance imaging |
WO2004016167A1 (en) * | 2002-08-16 | 2004-02-26 | The General Hospital Corporation | Non-invasive functional imaging of peripheral nervous system activation in humans and animals |
US7450983B2 (en) * | 2003-03-18 | 2008-11-11 | University Of Cincinnati | Automated brain MRI and CT prescriptions in Talairach space |
US20050267357A1 (en) * | 2003-10-21 | 2005-12-01 | Rao Stephen M | fMRI system for detecting symptoms associated with Attention Deficit Hyperactivity Disorder |
US20050085705A1 (en) * | 2003-10-21 | 2005-04-21 | Rao Stephen M. | fMRI system for use in detecting neural abnormalities associated with CNS disorders and assessing the staging of such disorders |
US20050107682A1 (en) * | 2003-10-21 | 2005-05-19 | Rao Stephen M. | fMRI system for use in assessing the efficacy of therapies in treating CNS disorders |
US20050215889A1 (en) | 2004-03-29 | 2005-09-29 | The Board of Supervisory of Louisiana State University | Methods for using pet measured metabolism to determine cognitive impairment |
US20070081700A1 (en) * | 2005-09-29 | 2007-04-12 | General Electric Company | Systems, methods and apparatus for creation of a database of images from categorical indices |
US20070081701A1 (en) * | 2005-09-29 | 2007-04-12 | General Electric Company | Systems, methods and apparatus for tracking progression and tracking treatment of disease from categorical indices |
US20070081699A1 (en) * | 2005-09-29 | 2007-04-12 | General Electric Company | Systems, methods and apparatus for diagnosis of disease from categorical indices |
US7929737B2 (en) | 2005-09-29 | 2011-04-19 | General Electric Company | Method and system for automatically generating a disease severity index |
WO2008005513A2 (en) * | 2006-07-06 | 2008-01-10 | Regents Of The University Of Minnesota | Analysis of brain patterns using temporal measures |
US9138634B2 (en) | 2006-12-18 | 2015-09-22 | Igt | Casino game with next round multipliers |
JP5138701B2 (ja) * | 2006-12-22 | 2013-02-06 | ワシントン・ユニバーシティ | 拡散光トモグラフィのための高性能イメージングシステム及び関連した使用方法 |
WO2008155682A1 (en) * | 2007-06-21 | 2008-12-24 | Koninklijke Philips Electronics N.V., | Model-based differential diagnosis of dementia and interactive setting of level of significance |
US8152616B2 (en) | 2007-10-24 | 2012-04-10 | Ernest Moody Revocable Trust | Casino game with pay line multipliers |
JP5140796B2 (ja) * | 2007-12-18 | 2013-02-13 | 株式会社国際電気通信基礎技術研究所 | 脳機能障害予測装置 |
US8626264B1 (en) | 2008-04-09 | 2014-01-07 | James T. Beran | Obtaining information about brain activity |
US9480425B2 (en) * | 2008-04-17 | 2016-11-01 | Washington University | Task-less optical mapping of dynamic brain function using resting state functional connectivity |
FR2931281B1 (fr) * | 2008-05-15 | 2014-07-18 | Univ Paris Curie | Procede et systeme automatise d'assistance au pronostic de la maladie d'alzheimer, et procede d'apprentissage d'un tel systeme |
US8199982B2 (en) | 2008-06-18 | 2012-06-12 | International Business Machines Corporation | Mapping of literature onto regions of interest on neurological images |
US8548823B2 (en) * | 2008-07-08 | 2013-10-01 | International Business Machines Corporation | Automatically determining ideal treatment plans for complex neuropsychiatric conditions |
US9198612B2 (en) | 2008-07-08 | 2015-12-01 | International Business Machines Corporation | Determination of neuropsychiatric therapy mechanisms of action |
US8388529B2 (en) * | 2008-07-08 | 2013-03-05 | International Business Machines Corporation | Differential diagnosis of neuropsychiatric conditions |
US8231541B2 (en) * | 2008-10-22 | 2012-07-31 | Sharp Laboratories Of America, Inc. | Asthma status scoring method and system with confidence ratings |
US8712499B2 (en) * | 2008-11-29 | 2014-04-29 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Quantitative oxygen imaging systems and methods using echo-based single point imaging |
US9734432B2 (en) * | 2009-03-20 | 2017-08-15 | Case Western Reserve University | Reducing acquisition time |
GB0913314D0 (en) * | 2009-07-31 | 2009-09-02 | Siemens Medical Solutions | Facilitated percist evaluation |
ME02347B (me) | 2009-10-19 | 2016-06-20 | Rostaquo S P A | Rostafuroksin za farmakogenomsko lečenje kardiovaskularnih stanja |
JP5816917B2 (ja) * | 2011-05-13 | 2015-11-18 | 本田技研工業株式会社 | 脳活動計測装置、脳活動計測方法、及び脳活動推定装置 |
HK1160580A2 (en) * | 2011-05-16 | 2012-07-20 | Global Advanced Vision Ltd | A method and system for determining a condition of a brain |
US20140350380A1 (en) * | 2011-09-19 | 2014-11-27 | The Feinstein Institute For Medical Research | Identification and uses of brain activity networks |
GB2491027A (en) * | 2012-05-16 | 2012-11-21 | Global Advanced Vision Ltd | A method and system for determining a condition of a brain |
JP6091852B2 (ja) * | 2012-11-13 | 2017-03-08 | 東芝メディカルシステムズ株式会社 | 核医学診断装置および画像処理プログラム |
TWI503103B (zh) * | 2013-04-12 | 2015-10-11 | Inst Nuclear Energy Res | A method of stimulating the formation of brain cognitive response images |
US10755529B2 (en) | 2014-09-24 | 2020-08-25 | Igt | Gaming system and method providing a video poker game with modifiers |
TWI651688B (zh) * | 2017-03-17 | 2019-02-21 | 長庚大學 | 利用磁振造影影像預測神經疾病的臨床嚴重度的方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4307726A (en) * | 1978-04-24 | 1981-12-29 | Paulson James C | Diagnostic evaluation, measurement, and analysis of functional activity in body organs that utilize transmembrane ion polarization and depolarization |
US4188956A (en) * | 1978-06-26 | 1980-02-19 | Roy John E | Method for the analysis, display and classification of multivariate indices of brain function--a functional electrophysiological brain scan |
US4532591A (en) * | 1982-08-03 | 1985-07-30 | Thomas Jefferson University | Method and apparatus for tomographic diagnosis |
US5331969A (en) * | 1985-07-30 | 1994-07-26 | Swinburne Limited | Equipment for testing or measuring brain activity |
US4736751A (en) * | 1986-12-16 | 1988-04-12 | Eeg Systems Laboratory | Brain wave source network location scanning method and system |
US5083571A (en) * | 1988-04-18 | 1992-01-28 | New York University | Use of brain electrophysiological quantitative data to classify and subtype an individual into diagnostic categories by discriminant and cluster analysis |
EP0355506B1 (de) * | 1988-08-16 | 1994-12-14 | Siemens Aktiengesellschaft | Anordnung zum Messen lokaler bioelektrischer Ströme in biologischen Gewebekomplexen |
US4977896A (en) * | 1989-05-26 | 1990-12-18 | Biomagnetic Technologies, Inc. | Analysis of biological signals using data from arrays of sensors |
US5269325A (en) * | 1989-05-26 | 1993-12-14 | Biomagnetic Technologies, Inc. | Analysis of biological signals using data from arrays of sensors |
US5299119A (en) * | 1989-07-06 | 1994-03-29 | Qmed, Inc. | Autonomic neuropathy detection and method of analysis |
US5215095A (en) * | 1990-08-10 | 1993-06-01 | University Technologies International | Optical imaging system for neurosurgery |
US5438989A (en) * | 1990-08-10 | 1995-08-08 | Hochman; Darryl | Solid tumor, cortical function, and nerve tissue imaging methods and device |
JP3221610B2 (ja) * | 1991-01-18 | 2001-10-22 | エイサ・インコーポレイテツド | 生化学的プロフィールから障害を検出又は類別する方法 |
EP0504027A3 (en) * | 1991-03-15 | 1993-04-21 | Centro De Neurociencias De Cuba | Method and system for three-dimensional tomography of activity and connectivity of brain and heart electromagnetic waves generators |
US5189026A (en) * | 1991-06-07 | 1993-02-23 | Fractal Laboratories, Inc. | Treatment of human diseases involving dysregulation or dysfunction of the nervous system |
US5262945A (en) * | 1991-08-09 | 1993-11-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method for quantification of brain volume from magnetic resonance images |
US5445937A (en) * | 1991-12-24 | 1995-08-29 | The University Of Kentucky Research Foundation | Detection of Alzheimer's disease and other diseases using an improved photoaffinity labeling method |
JPH05221303A (ja) * | 1992-02-17 | 1993-08-31 | Mazda Motor Corp | 車両のスリップ制御装置 |
-
1995
- 1995-01-27 US US08/379,056 patent/US5632276A/en not_active Expired - Lifetime
-
1996
- 1996-01-11 EP EP96905154A patent/EP0869736A4/en not_active Withdrawn
- 1996-01-11 CA CA2211537A patent/CA2211537C/en not_active Expired - Fee Related
- 1996-01-11 AU AU48987/96A patent/AU4898796A/en not_active Abandoned
- 1996-01-11 JP JP8522908A patent/JPH10512784A/ja active Pending
- 1996-01-11 WO PCT/US1996/000568 patent/WO1996022729A1/en active Application Filing
- 1996-01-23 IL IL11686696A patent/IL116866A/xx not_active IP Right Cessation
- 1996-09-04 US US08/706,478 patent/US5873823A/en not_active Expired - Lifetime
-
2006
- 2006-08-14 JP JP2006221155A patent/JP2007018524A/ja active Pending
-
2007
- 2007-04-10 JP JP2007102591A patent/JP4309931B2/ja not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008501957A (ja) * | 2004-06-02 | 2008-01-24 | シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド | 陽電子放射断層撮影法画像を用いた統計学的分析によるアルツハイマー病の自動化された検出 |
US7873405B2 (en) | 2004-06-02 | 2011-01-18 | Siemens Medical Solutions Usa, Inc. | Automated detection of Alzheimer's disease by statistical analysis with positron emission tomography images |
JP2008026144A (ja) * | 2006-07-21 | 2008-02-07 | Fujifilm Ri Pharma Co Ltd | 画像診断支援システム及び方法 |
JP4302183B1 (ja) * | 2008-07-28 | 2009-07-22 | 日本メジフィジックス株式会社 | 脳神経疾患検出技術 |
WO2010013300A1 (ja) * | 2008-07-28 | 2010-02-04 | 日本メジフィジックス株式会社 | 脳神経疾患検出技術 |
Also Published As
Publication number | Publication date |
---|---|
JP2007307360A (ja) | 2007-11-29 |
AU4898796A (en) | 1996-08-14 |
EP0869736A4 (en) | 2004-03-31 |
IL116866A (en) | 2000-02-29 |
US5632276A (en) | 1997-05-27 |
EP0869736A1 (en) | 1998-10-14 |
US5873823A (en) | 1999-02-23 |
IL116866A0 (en) | 1996-07-23 |
JP2007018524A (ja) | 2007-01-25 |
WO1996022729A1 (en) | 1996-08-01 |
CA2211537A1 (en) | 1996-08-01 |
CA2211537C (en) | 2012-03-20 |
JP4309931B2 (ja) | 2009-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH10512784A (ja) | 患者スクリーニング用マーカー | |
Ahmed et al. | Single volume image generator and deep learning-based ASD classification | |
US7428323B2 (en) | Method and system for automatic diagnosis of possible brain disease | |
Andrews et al. | Distinct representations for facial identity and changeable aspects of faces in the human temporal lobe | |
Saygin | Superior temporal and premotor brain areas necessary for biological motion perception | |
Uribe et al. | Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis | |
US9839392B2 (en) | Method and system for estimating brain concussion | |
Catani et al. | Occipito‐temporal connections in the human brain | |
Marcus et al. | Open Access Series of Imaging Studies (OASIS): cross-sectional MRI data in young, middle aged, nondemented, and demented older adults | |
CN106659424B (zh) | 医用图像显示处理方法、医用图像显示处理装置及程序 | |
CN110689536B (zh) | 基于多模态磁共振影像的大脑灰质及白质追踪方法及装置 | |
JP2009542351A (ja) | 時間的尺度を使用した脳パターンの解析 | |
JP2022507861A (ja) | 脳機能地図のサル-ヒト種間移行に基づいて精神疾患の個別的予測を行う方法およびシステム | |
Siuda-Krzywicka et al. | Color categorization independent of color naming | |
KR20190086282A (ko) | 뇌 기능 연결성 분석을 이용한 어지럼증 진단 방법 및 이를 적용하는 시스템 | |
CN116784820A (zh) | 一种基于种子点连接的脑功能网络构建方法及系统 | |
Yao et al. | Gait characteristics and brain activity in Parkinson’s disease with concomitant postural abnormalities | |
Lemoine et al. | The specific role of the striatum in interval timing: The Huntington’s disease model | |
JP2004340954A (ja) | 脳画像データ処理システム、方法、プログラムおよび記録媒体 | |
Taskin et al. | Retinal ganglion cell endowment is correlated with optic tract fiber cross section, not density | |
Song et al. | Functional brain connections identify sensorineural hearing loss and predict the outcome of cochlear implantation | |
Mo et al. | Decreased cortical thickness and normal regional homogeneity underlying cognitive impairment in cerebral small vessel disease | |
WO2005112755A2 (en) | Morphometric analysis of brain structures | |
JP2004239782A (ja) | 脳画像データ処理システム、方法、プログラムおよび記録媒体 | |
Zanin et al. | A fast transform for brain connectivity difference evaluation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050726 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20051025 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20051205 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060126 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060516 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060814 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061010 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070109 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070410 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070605 |